Page last updated: 2024-09-03

sr 46349b and ticlopidine

sr 46349b has been researched along with ticlopidine in 1 studies

Compound Research Comparison

Studies
(sr 46349b)
Trials
(sr 46349b)
Recent Studies (post-2010)
(sr 46349b)
Studies
(ticlopidine)
Trials
(ticlopidine)
Recent Studies (post-2010) (ticlopidine)
511710,2891,8934,671

Protein Interaction Comparison

ProteinTaxonomysr 46349b (IC50)ticlopidine (IC50)
Alpha-2A adrenergic receptorHomo sapiens (human)0.382
Cytochrome P450 2D6Homo sapiens (human)6.2928
Alpha-2B adrenergic receptorHomo sapiens (human)0.304
Alpha-2C adrenergic receptorHomo sapiens (human)1.175
Cytochrome P450 2B6Homo sapiens (human)0.405
Cytochrome P450 2C19Homo sapiens (human)0.6678
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.426

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernat, A; Dol, F; Herbert, JM; Rinaldi, M; Sainte-Marie, M1

Other Studies

1 other study(ies) available for sr 46349b and ticlopidine

ArticleYear
Potentiating effect of clopidogrel and SR 46349, a novel 5-HT2 antagonist, on streptokinase-induced thrombolysis in the rabbit.
    Thrombosis and haemostasis, 1993, Mar-01, Volume: 69, Issue:3

    Topics: Animals; Bleeding Time; Clopidogrel; Drug Synergism; Fibrinolytic Agents; Fluorobenzenes; Jugular Veins; Male; Phenols; Platelet Aggregation Inhibitors; Rabbits; Serotonin Antagonists; Streptokinase; Thrombolytic Therapy; Thrombosis; Ticlopidine

1993